EpigeneticsNature Biotechnology · 26 Jul 2026
Signal77·StrongRegulators signal caution on epigenetic clocks as trial endpoints
A regulatory workshop summary concluded that methylation-based age estimates are not yet acceptable as standalone efficacy endpoints. Clocks may…
EvidenceStrongMarket relevanceHigh5 min read
